alpha-aminopyridine has been researched along with Exocrine Pancreatic Insufficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akshintala, VS; Cebotaru, L; Cutting, GR; Dezube, R; Faghih, M; Jennings, MT; Kamal, A; Lechtzin, N; Merlo, CA; Singh, VK; West, NE; Whitcomb, DC | 1 |
1 other study(ies) available for alpha-aminopyridine and Exocrine Pancreatic Insufficiency
Article | Year |
---|---|
Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis.
Topics: Adult; Aged; Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Exocrine Pancreatic Insufficiency; Female; Humans; Indoles; Male; Middle Aged; Quinolones; Retrospective Studies | 2019 |